Skip to content

Luminoma Diagnostics Ltd

Developing the LumAssure™, a portable diagnostic-aid using Raman spectroscopy to non-invasively detect skin cancer.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Luminoma Diagnostics Ltd is a New Zealand startup company developing the LumAssure™, a portable diagnostic-aid that indicates whether a skin lesion is likely to be malignant or benign within seconds. The device uses Raman spectroscopy to non-invasively analyse the biochemical 'fingerprint' within the lesion for changes indicative of cancer. In a preliminary study, the LumAssure™ correctly identified skin cancers at 99% while correctly identifying 72% of benign lesions.

History

Luminoma Diagnostics Ltd is a New Zealand startup company. The company is developing the LumAssure™, a portable diagnostic-aid that indicates whether a skin lesion is likely to be malignant or benign within seconds. The LumAssure™ uses Raman spectroscopy to non-invasively analyse the biochemical 'fingerprint' within the lesion for changes that are indicative of cancer. In a preliminary study, the LumAssure™ was able to correctly identify skin cancers at 99% while correctly identifying 72% of benign lesions.

Products and positioning

  • LumAssure™

    A portable diagnostic-aid that indicates whether a skin lesion is likely to be malignant or benign within seconds.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/luminoma-diagnostics-ltd · Editorial policy · How profiles are compiled